There are only two commonly upregulated RBPs including DNMT3B and NYNRIN out of 18 and 8 upregulated RBPs in high‐risk adult and pediatric AML, further indicating the differences in regulatory mechanisms. The gene discussed is NYNRIN; the disease is acute myeloid leukemia.